Cupid Limited Receives CE (EU IVDR) Certification for HIV 1&2 and Hepatitis B IVD Test Kits, Expanding Global Market Access in Diagnostics
Jan 29, 2026
New Delhi [India], January 29: Cupid Limited, (BSE - 530843, NSE - CUPID), a diversified Indian healthcare and consumer products company with a growing focus on in-vitro diagnostics (IVD),wellness, and personal care, announced that it has received CE (EU IVDR) Certification for two in-vitro diagnostic (IVD) products - the CupiKIT HIV 1&2 Antibody Test Kit and the CupiKITHepatitis B Surface Antigen (HBsAg) Test Kit.
Read More...
